Cardiac Arrest Treatment Market, By Type (Drugs, Medical Devices, Others), By Service Provider (Hospitals, Pharmacies, Others), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

Cardiac arrest is a serious heart condition. In cardiac arrest, the heart ceases to beat. It’s also known as sudden cardiac death. The word arrest means to stop or bring to a halt. Cardiac arrest is severe health issue. The percentage of death due to cardiac arrest is more in United States. One of the report states that every year half a million people experience cardiac arrest in the United States. In technical terms, heartbeat of human being is controlled by electrical impulses. When these impulses tend to change pattern, the heartbeat starts to change accordingly hence it become irregular pattern. This is called as arrhythmia. Some arrhythmias are slow, others are rapid. Cardiac arrest occurs when the rhythm of the heart stops. Cardia arrest can lead to death or disability. It can be fatal hence needs to take immediate assistance if showing some symptoms. Quick response can save a life.

The whole world is facing an increase in number of cardiovascular diseases incidence. There are many issues such as agonal breathing or apnea, which are well known to lead cardiac arrest, are seeing most of the people affected. Other reasons also include the day to day life changes, consumption of alcohol, tobacco, lack of exercise and imperfection in work life balance. Obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles are the primary causes of heart failure and cardiac arrest. In terms of treatment, the global cardiac arrest treatment market has been segmented into drugs and medical devices. The drugs segment has been categorized into vasopressors, anti-arrhythmic drugs, anticholinergic drugs, corticosteroids, fibrinolytic drugs, beta blockers, and others. Compared to Europe and North America, the cardiac arrest treatment market is growing very fast in Europe. Factors contributing to strong market growth in Asia Pacific are increase in incidence of sudden cardiac arrest, large patient base and corporate defibrillation programs, increase in disposable income, and subsequent spending on health care. A number of factors can cause sudden cardiac arrest. Two of the most common are ventricular and atrial fibrillation. Human heart has four chambers. The two lower chambers are the ventricles. In ventricular fibrillation, these chambers quiver out of control. This causes the heart’s rhythm to change dramatically. The ventricles begin to pump inefficiently, which severely decreases the amount of blood pumped through the body. In some cases, the circulation of blood stops completely. This may lead to sudden cardiac death. The heart can also stop beating efficiently after an arrhythmia in the upper chambers. These chambers are known as the atria. Atrial fibrillation begins when the sinoatrial node doesn’t send out the correct electrical impulses. Sinoatrial node is located in the right atrium. It regulates how quickly the heart pumps blood. When the electrical impulse goes into atrial fibrillation, the ventricles can’t pump blood out to the body efficiently. The most frequent cause of cardiac arrest is ventricular fibrillation.

Some of the impact factors:

  • Lifestyle choices such as alcohol and tobacco use, lack of exercise and a hectic work schedule all this will lead to growth in the global cardiac arrest treatment market over the forecast period 2028
  • Rise in the number of people afflicted by diseases such as diabetes, obesity, high blood pressure is projected to drive demand for cardiac arrest treatment
  • Growing competition is projected to fuel the market growth.

What does this report provide?

The Cardiac Attack Treatment report sheds light on the complete competitive landscape of the global market and in-depth market segmentation by regions, product types and application. This Cardiac Arrest Treatment report also covers all the provinces and countries of the globe, which shows a regional development status, including market size, volume as well as value. The report provides a detailed pipeline analysis of Cardiac Arrest Treatment. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.

Market Segmentation: 

By Type:
    • Drugs
    • Medical Devices
    • Others 
By Service Provider:
    • Hospitals
    • Pharmacies
    • Others
By Region:
    • North America 
        ◦ North America, by Country 
            ▪ US 
            ▪ Canada 
            ▪ Mexico 
        ◦ North America, by Type
        ◦ North America, by Service Provider 
    • Europe 
        ◦  Europe, by Country 
            ▪ Germany 
            ▪ UK 
            ▪ France 
            ▪ Italy 
            ▪ Spain 
            ▪ The Netherlands 
            ▪ Rest of Western Europe 
        ◦ Europe, by Type
        ◦ Europe, by Service Provider 
    • Asia Pacific 
        ◦ Asia Pacific, by Country 
            ▪ China 
            ▪ India 
            ▪ Japan 
            ▪ South Korea 
            ▪ Australia 
            ▪ Indonesia 
            ▪ Rest of Asia Pacific 
        ◦ Asia Pacific, by Type
        ◦ Asia Pacific, by Service Provider 
 
    • Middle East & Africa
        ◦ Middle East, by Country 
            ▪ UAE 
            ▪ Saudi Arabia 
            ▪ Qatar 
            ▪ Iran 

          ▪ South Africa
            ▪ Rest of Middle East & Africa
        ◦ Middle East & Africa, by Type
        ◦ Middle East & Africa, by Service Provider 
    • South America 
        ◦ South America, by Country 
            ▪ Brazil 
            ▪ Argentina

           ▪ Rest of South America
        ◦ South America, by Type
        ◦ South America, by Service Provider

Key Players: Pfizer Inc., Novartis AG, Abbott, Bayer AG, Amgen Inc., Boston Scientific Corporation, GE Healthcare.

Years Covered in the Study:

Historic Year: 2016-2017

Base Year:2018

Estimated Year: 2019

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for Cardiac arrest treatment market on regional and global basis.
  • To identify major segments in the Cardiac arrest treatment market and evaluate their market shares and demand.
  • To provide a competitive scenario for the Cardiac arrest treatment market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of the Cardiac arrest treatment market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision-making process.
  • Market size estimation of the Cardiac arrest treatment market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the Cardiac arrest treatment market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis